These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7445277)

  • 1. [Circulating polynucleotide and DNA antibody content and the DNase activity of the blood in clinical and experimental lupus nephritis].
    Demin AA; Lapteva GF; Semenova LA; Kovalenko GA
    Urol Nefrol (Mosk); 1980; (6):43-4. PubMed ID: 7445277
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of avidity of circulating anti-DNA antibodies on murine lupus nephritis.
    Granholm NA; Graves K; Cavallo T
    J Clin Lab Immunol; 1985 Apr; 16(4):211-5. PubMed ID: 4020851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA antibodies, DNA and DNAase plasma activity in children suffering from systemic lupus erythematosus].
    Isaeva LA; Levina SG; Klimov VIu; Belokrinitskiĭ DV; Prozorovskaia NN
    Vopr Revm; 1973; 13(4):56-60. PubMed ID: 4589786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-immunological characteristics of rheumatoid arthritis and systemic lupus erythematosus].
    Mikunis RI; Kozlova TV
    Ter Arkh; 1983; 55(7):46-9. PubMed ID: 6623383
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
    Suzuki N; Harada T; Mizushima Y; Sakane T
    J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
    Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
    J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.
    Lefkowith JB; Kiehl M; Rubenstein J; DiValerio R; Bernstein K; Kahl L; Rubin RL; Gourley M
    J Clin Invest; 1996 Sep; 98(6):1373-80. PubMed ID: 8823302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC; Malone CC; Meyers C; Decker P; Muller S
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum proteins reacting with DNA and DNA-RNA hybrids in New Zealand mice of different ages].
    Poverennyĭ AM; Nasonova VA; Pleskovskaia GN; Bryksina LE; Podgorodnichenko VK
    Dokl Akad Nauk SSSR; 1980; 251(5):1278-80. PubMed ID: 6156065
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
    Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly cationic anti-DNA antibodies in patients with lupus nephritis analyzed by two-dimensional electrophoresis and immunoblotting.
    Kohro-Kawata J; Wang P; Kawata Y; Matsuzaki M; Nakamura K
    Electrophoresis; 1998 Jun; 19(8-9):1511-5. PubMed ID: 9694304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.